指南与共识儿科与产科急症消化、代谢与肾脏急症

儿科急诊医师在急性荨麻疹管理中是否遵循指南推荐

Do Pediatric Emergency Physicians Comply With Guideline Recommendations in Management of Patients With Acute Urticaria?
指南 / 共识 · Pediatr Emerg Care · 2021-01-01
一句话结论儿科急诊医师对急性荨麻疹的实际处置与现行指南及自身理论认知差距明显,培训可提升依从性。

该前瞻性研究对48名儿科医师进行急性荨麻疹(AU)诊治的理论培训,比较培训前6个月与培训后1年儿科急诊(PED)收治的AU患儿(培训前417例、培训后1085例)的治疗选择。培训前问卷显示35%仅用H1抗组胺药、50%选用第二代H1抗组胺药(2nd-GAH)、75%偏好口服给药、85.4%并非对所有患者使用全身性糖皮质激素(sCS)。培训前后比较,第一代H1抗组胺药(1st-GAH)偏好率由68.4%降至30.3%,sCS偏好率由58.5%降至25.7%,2nd-GAH偏好率由31.7%升至69.7%(均P < 0.001);离院时未处方任何治疗的比例由10.8%降至3%(P < 0.05);家庭治疗选择中1st-GAH由11.5%降至5%,2nd-GAH由78.7%升至91.5%(均P < 0.001)。作者认为培训可增强儿科医师对现行指南推荐的依从性。

要点

  • 培训前仅50%儿科医师选用第二代H1抗组胺药,35%仅用H1抗组胺药,与指南推荐存在差距。
  • 培训后第一代H1抗组胺药偏好率由68.4%降至30.3%,第二代由31.7%升至69.7%(P < 0.001)。
  • 培训后全身性糖皮质激素偏好率由58.5%降至25.7%(P < 0.001)。
  • 培训后离院时未处方任何治疗的比例由10.8%降至3%(P < 0.05)。
  • 家庭治疗中第二代H1抗组胺药由78.7%升至91.5%,第一代由11.5%降至5%(均P < 0.001)。

适用人群与场景

  • 在儿科急诊(PED)因急性荨麻疹(AU)就诊的儿童(培训前6个月417例,培训后1年1085例)
  • 参与培训的48名儿科医师

研究设计与关键结果

  • 前瞻性研究:对48名儿科医师进行急性荨麻疹诊治理论培训,比较培训前6个月与培训后1年PED收治的AU患儿治疗选择。
  • 培训前问卷:35%仅用H1抗组胺药,50%选用第二代H1抗组胺药,75%偏好口服给药,85.4%并非对所有患者使用全身性糖皮质激素。
  • 培训前 vs 培训后:第一代H1抗组胺药偏好率68.4% vs 30.3%,全身性糖皮质激素偏好率58.5% vs 25.7%,第二代H1抗组胺药偏好率31.7% vs 69.7%(均P < 0.001)。
  • 离院时未处方任何治疗:培训前10.8% vs 培训后3%(P < 0.05)。
  • 家庭治疗选择:第一代H1抗组胺药11.5% vs 5%,第二代H1抗组胺药78.7% vs 91.5%(均P < 0.001)。

证据类型、等级与局限

  • 证据类型:前瞻性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,培训可增强儿科医师对现行荨麻疹指南推荐的依从性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To determine the level of knowledge and practical preferences of pediatricians regarding acute urticaria (AU) management and to assess the effects of training provided in accordance with the current urticaria guideline recommendations on pediatricians who work in the pediatric emergency department (PED).

METHODS: A theoretical training was provided to pediatricians regarding the diagnosis and treatment of AU in line with current urticaria guideline recommendations. Before the training, pediatricians completed a 10-item questionnaire. This prospective study assesses their treatment approaches in patients admitted to PED because of AU during the 6-month period before and the 1-year period after training.

RESULTS: Four hundred seventeen children in the pretraining and 1085 children in the posttraining periods were treated for AU in PED. Forty-eight pediatricians participated in the training. According to their questionnaire responses, 35% of them used only H1 antihistamine (AH) treatment, 50% used second-generation H1 AH (2nd-GAH) as AHs, 75% preferred the oral route of administration, and 85.4% did not administer systemic corticosteroid (sCS) to all patients. Comparing the practice approaches of the pediatricians in the pretraining and posttraining periods, first-generation H1 antihistamine (1st-GAH) preference rate decreased from 68.4% to 30.3% and the sCS preference rate decreased from 58.5% to 25.7%, while the 2nd-GAH preference rate increased from 31.7% to 69.7% (P < 0.001 for all). No treatments were prescribed for 10.8% of patients before the training and 3% after the training during discharge at home (P < 0.05). Comparing the home treatment choices of the pediatricians in the pretraining and posttraining periods, 1st-GAH preference rate decreased from 11.5% to 5%, while the 2nd-GAH preference rate increased from 78.7% to 91.5% (for both parameters, P < 0.001).

CONCLUSIONS: Practical treatment preferences of pediatricians in the treatment of children with AU differ considerably from both current guideline recommendations and their own theoretical knowledge, and training can enhance pediatricians' compliance with current guideline recommendations.

来源:Pediatr Emerg Care,查看原文。版权归原作者所有。

参考来源

  1. Yiğit RE, Cavkaytar O, Besli GE, et al. Do Pediatric Emergency Physicians Comply With Guideline Recommendations in Management of Patients With Acute Urticaria? Pediatr Emerg Care. 2021. PMID: 34043307. doi:10.1097/PEC.0000000000002327

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。